pembrolizumab therapy for microsatellite instability-high colorectal cancer
Published 7 years ago • 1.7K plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
0:46
microsatellite instability serves as a predictive biomarker of response to pembrolizumab
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
4:56
asco: pembrolizumab vs. chemotherapy for msi-h metastatic colorectal cancer
-
9:02
pembrolizumab in msi-h crc tumors
-
9:25
debate: msi high colon cancer - immunotherapy
-
6:56
keynote-177 results: pembrolizumab versus chemotherapy for patients with msi-h/dmmr colorectal c...
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
2:59
pembrolizumab (keytruda) in a metastatic colon cancer patient with microsatellite instability
-
2:56
keynote-177: final pfs analysis of pembrolizumab in patients with msi-h/dmmr mcrc
-
1:38
immuno-oncology in msi colorectal cancer
-
5:20
pembrolizumab improves on chemo in msi-h/dmmr mcrc
-
3:10
case 4: metastatic colon cancer, msi-high
-
1:54
pembrolizumab in advanced gastric cancer treatment
-
3:21
frontline therapy for stage iv right-sided crc
-
1:16
pochi: pembrolizumab, capox and bevacizumab in pmmr/mss colorectal cancer
-
0:50
zev wainberg, md, on the role of pembrolizumab for msi high crc patients and its use in therapy
-
35:42
immunotherapy in crc | 2023 best of gi cancer conference
-
1:29
the role of immunotherapy in colorectal cancer
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc